EPMN licenses delivery technology from VLTS

Valentis (VLTS) granted Epimmune (EPMN) a non-exclusive license to its Polymeric, Interactive, Non-Condensing (PINC) gene delivery technology, which EPMN will use to develop DNA vaccines to treat HIV ...